17 June - 15:00 - 16:00 BST / 10:00 - 11:00 ET / 16:00 – 17:00 CET
Navigating the Saudi Market: Insights into Incentives and New Regulatory Frameworks 

Overview:

Join PI Pharma Intelligence and HEPA for an exclusive session, which will explore key topics impacting market access and regulatory changes in Saudi Arabia. As the country’s healthcare landscape continues to evolve, staying up to date on the latest incentives and regulatory developments is crucial for pharmaceutical professionals.

Session Topics:

• Latest Incentives for Accessing the Saudi Market
• This session will provide valuable insights into the latest government initiatives and incentives designed to facilitate market access in Saudi Arabia. Learn about the opportunities and the strategies that can help pharmaceutical companies successfully enter and expand in the Saudi market.
• New Regulations Regarding Economic Evaluation Studies in the Saudi Market
• Stay informed about the new regulations governing economic evaluation studies in Saudi Arabia. Our experts will guide you through the latest requirements and how these regulations influence market entry, product evaluation, and development strategies in the country.

Why Attend?

• Unlock Market Opportunities: Gain a clear understanding of the latest incentives available to support your entry and growth in the Saudi market.
• Navigate New Regulatory Frameworks: Learn how to effectively adapt to the new economic evaluation regulations in Saudi Arabia.
• Gain Expert Insights: Hear from industry experts who will share practical advice and key strategies based on their in-depth knowledge of Saudi Arabia’s market dynamics. 

Target audience

• Delegates from the regulatory affairs industry who wish to obtain a better insight into the regulatory landscape in Saudi Arabia and a comprehensive understanding of the subject.
• Regulatory affairs professionals, pharmaceutical industry executives, and researchers involved in drug development and commercialisation. Additionally, it is relevant for policymakers and legal professionals who are involved in crafting and implementing regulations

Speakers

Mr. Hazem Al-Yacoub: CEO and Co-founder at Pi Pharma Intelligence has 20-year experience in the pharmaceutical industry, marked by diverse roles with major players such as Bayer, AstraZeneca, Ferring, and, notably, Tabuk Pharmaceuticals, underscores his deep understanding of the intricacies of the field. The pivotal shift in the last seven years towards a more involved role in decision-making, particularly in product selection and sourcing for the MENA region, showcases his strategic insights. Hazem holds a Bachelor of Science in Pharmacy from the University of Jordan.

Dr. Muhannad Alharbi: health economics consultant and Managing Director of HEPA Company. He holds a PharmD degree from King Abdul-Aziz University, Saudi Arabia and received his master’s degree in Drug Development and Product management focused on health economics and business development from University of California, San Diego, US. He is hired as health economic consultant and Investment Development Consultant at Saudi FDA in 2020 and 2024 respectively. His background experience shaped from working at pharmaceutical industries and consulting firm as Health Economics Consultant for Public sector, Lecturer in Saudi Health Saudi Commission for Health Specialists, and A Peer Reviewer in ISPOR European and United States. With his team, over 80 projects have executed in patient access and economic evidence generation across gulf countries.

This webinar is sponsored by PI Pharma Intelligence and HEPA

               

Disclaimer: Whilst TOPRA is running this webinar for PI Pharma Intelligence and HEPA, this is not an endorsement of PI Pharma Intelligence or HEPA, PI Pharma Intelligence's or HEPA's affiliates, employees or its products and services. TOPRA is also not responsible for the content or views expressed during the webinar.

How do I register?

Simply log in or create an account and register below.

Pricing

• Members: free
• Non-members: free

Terms and Conditions

By purchasing this webinar, you are agreeing to TOPRA's training terms and conditions.